Concepedia

John Hohneker

JH

Statistics

Publications

26

Citations

2.2K

H-Index

21

Active since

1989

Affiliations

Research Triangle Park Foundation(Current)

Novartis (United States)

Johns Hopkins University

University of Chicago

Research Network (United States)

John Hohneker is an author at Research Triangle Park Foundation specializing in chemotherapy, pharmacology, and medicine.

Publications per year

1989–2012

26

Publications

26

Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

Adam Brufsky, W G Harker, J. Thaddeus Beck et al. · Journal of Clinical Oncology · 2006 · 321 citations · Full text

, , +17

Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer.

Simon A. Jones, Eric P. Winer, C Vogel et al. · Journal of Clinical Oncology · 1995 · 194 citations

, , +13

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer.

Barbara Weber, Charles Vogel, Stephen E. Jones et al. · Journal of Clinical Oncology · 1995 · 193 citations

, , +14

Final 5‐year results of Z‐FAST trial

Adam Brufsky, W G Harker, J. Thaddeus Beck et al. · Cancer · 2011 · 190 citations

, , +17

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase.

Sharyn D. Baker, S P Khor, Alex A. Adjei et al. · Journal of Clinical Oncology · 1996 · 138 citations

, , +17

1–5 of 26